申请人:Vectus Biosystems Limited
公开号:US10919863B2
公开(公告)日:2021-02-16
The present invention relates to compounds and their use in the prophylactic and/or therapeutic treatment of pulmonary fibrosis and/or related conditions.
本发明涉及化合物及其在肺纤维化和/或相关疾病的预防和/或治疗中的用途。